Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TruB pseudouridine synthase family member 1 (TRUB1) is a highly conserved enzyme responsible for catalyzing the formation of pseudouridine (Ψ) at position 55 in specific mitochondrial tRNAs, a key modification that ensures proper RNA structure and mitochondrial translation. TRUB1 is widely expressed in human tissues and localizes primarily to the nucleus with additional presence in mitochondria. Beyond its canonical enzyme function in tRNA modification, TRUB1 also regulates maturation of let-7 microRNA family members independently of its enzymatic activity, by directly binding to primary miRNA transcripts and promoting their processing. While dysfunction of TRUB1 is linked to defects in mitochondrial protein synthesis and has been associated with rare mitochondrial diseases, there are currently no drugs that directly target TRUB1, and it is not considered a classic therapeutic target for drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TruB pseudouridine synthase family member 1 (TRUB1).